Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-13

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves Aurobindo Pharma Limited's supplemental application for a generic telmisartan and hydrochlorothiazide combination tablet for treating hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)